Analyst Coverage

Firm Analyst Name
Thomas Shrader, PhD, CFA
Whitney Ijem
Morgan Stanley
Michael Ulz

Sigilon Therapeutics, Inc. is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding Sigilon Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Sigilon Therapeutics, Inc. or its management. Sigilon Therapeutics, Inc. does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.